The current coronavirus disease 2019 (COVID-19) pneumonia pandemic, caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading globally at an …

D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated
degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of …

Background Objective testing for DVT is crucial because clinical assessment alone is
unreliable and the consequences of misdiagnosis are serious. This guideline focuses on the …

D-dimer is the smallest fibrinolysis-specific degradation product found in the circulation. The
origins, assays, and clinical use of D-dimer will be addressed. Hemostasis (platelet and …

Venous thromboembolism (VTE) is the leading cause of morbidity and mortality among
hospitalized patients. We searched the PubMed database and reviewed the articles …

Deep venous thrombosis (DVT) is part of a spectrum of venous thromboembolic disorders
that includes superficial thrombophlebitis and pulmonary embolism. 1 DVT may be defined …

Background: Pulmonary embolism (PE) is a leading cause of maternal mortality in the
developed world. Along with appropriate prophylaxis and therapy, prevention of death from …

Pregnancy is associated with an increased risk of venous thromboembolism (VTE). D-dimer
is a biomarker used as an exclusion criterion of VTE disease, but its usefulness during …

Background Pulmonary embolism (PE) is a leading cause of maternal mortality in the
developed world. Along with appropriate prophylaxis and therapy, prevention of death from …

D-dimer is a global indicator of coagulation activation and fibrinolysis and, therefore, an
indirect marker of thrombotic activity. The utility of D-dimer measurement has been …